US FirstQuarter GDP Growth Revised Down to 16 Annualized Rate OCCI Q1 2026 Earnings Massive EPS Miss Triggers Sharp Decline ImmunityBio Surges on FDA Review Acceptance for ANKTIVA Label Expansion